Table 3 Differences in FDG and FMISO PET data before and after chemotherapy (increase in FMISO uptake; increase in mean SUV of FDG uptake); * kidney metastasis as well as an early local tumour progression; †local PR but disseminated lung metastases.
Pat. | FMISO | FDG | ||||
|---|---|---|---|---|---|---|
Local Tumour Response | ||||||
SUV mean post-prae Cht. | Tu./Musc. post-prae Cht. | SUV mean post-prae Cht. | SUV max. post-prae Cht. | post Cht. | post RT/Cht. | |
1 | -0.50 | -0.08 | -2.00 | -4,16 | PR | CR |
2 | -0.80 | -0.19 | -9.00 | -10.50 | PR | |
3 | 0.00 | -0.14 | -7.00 | -8.32 | PR | CR |
4 | -1.50 | -4.34 | -5.70 | -9.62 | PR | PR |
5 | -0.20 | -0.15 | +0.40 | -0.62 | PR | PR* |
6 | +0.20 | +0.18 | -0.60 | -1.22 | SD | SD |
7a | -0.60 | -0.11 | +2.00 | +0.14 | SD | SD |
7b | -0.60 | -0.34 | -3.50 | -4.70 | PR | PR |
8 | -0.30 | -0.41 | +8.10 | +12.59 | SD | PR † |
Mean | -0.48 | -0.62 | -1.92 | -2.93 | ||
SD | 0.17 | 0.47 | 1.73 | 2.34 | ||